Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOVEL LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 33
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 34
  • 0 comments

FDA approve ASPIRIN; BUTALBITAL; CAFFEINE

Comment Full text

SUN PHARM INDS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 28
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

ADAPTIS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 29
  • 0 comments

FDA approve ETODOLAC

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 31
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 35
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

TARO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 24
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

UNICHEM

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 22
  • 0 comments

FDA approve ETODOLAC

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 30
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

TARO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 29
  • 0 comments

FDA approve IBUPROFEN

Comment Full text
  • Previous
  • 196
  • 197
  • 198
  • 199
  • 200
  • Next

Search

News categories

  • Technical Exchange News(9878)
  • Event(407)
  • SEC News(167415)
  • FDA Approval(9345)
  • Company Report(721)
  • Business News(111254)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin